Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile

Vaccines are considered to be the most beneficial means for combating the COVID-19 pandemic. Although vaccines against SARS-CoV-2 have demonstrated excellent safety profiles in clinical trials, real-world surveillance of post-vaccination side effects is an impetus. The study investigates the short-t...

Full description

Bibliographic Details
Main Authors:	Abdulaziz Ibrahim Alzarea, Yusra Habib Khan, Ahmed D. Alatawi, Abdullah Salah Alanazi, Sami I. Alzarea, Muhammad Hammad Butt, Ziyad Saeed Almalki, Abdullah K. Alahmari, Tauqeer Hussain Mallhi
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Vaccines
Subjects:	COVID-19 vaccines Oxford-AstraZeneca Pfizer-BioNTech safety profile side effects
Online Access:	https://www.mdpi.com/2076-393X/10/6/924

Similar Items

An Immunological Review of SARS-CoV-2 Infection and Vaccine Serology: Innate and Adaptive Responses to mRNA, Adenovirus, Inactivated and Protein Subunit Vaccines
by: Suhaila A. Al-Sheboul, et al.
Published: (2022-12-01)

Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis
by: Abdulaziz Alhossan, et al.
Published: (2022-12-01)

Anti-S and Anti-N Antibody Responses of COVID-19 Vaccine Recipients
by: Abdel-Ellah Al-Shudifat, et al.
Published: (2023-08-01)

Effect of different COVID-19 vaccines on some biomarkers in diabetics
by: Munther Kamil Oudha, et al.
Published: (2023-04-01)

Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
by: Uraporn Phumisantiphong, et al.
Published: (2023-04-01)

Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers
by: Sylwia Kałucka, et al.
Published: (2022-03-01)

Systemic and cutaneous side effects of COVID-19 vaccines in Iraq, A cross-sectional study
by: Rzan Abdulhasan Al-Battat, et al.
Published: (2024-05-01)

Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines
by: Joanna Szczepanek, et al.
Published: (2022-01-01)

Biochemical Action of Vaccines in Iraqi Patients with COVID-19 Infection
by: Rasha Zuhair Jasim
Published: (2023-08-01)

COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series
by: Shitiz Sriwastava, et al.
Published: (2022-03-01)

Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study
by: Jehad Aldali, et al.
Published: (2023-01-01)

"Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
by: Ahmed Samir, et al.
Published: (2023-03-01)

Reactogenicity and Immunogenicity of the Pfizer and AstraZeneca COVID-19 Vaccines
by: Waleed H. Mahallawi, et al.
Published: (2021-12-01)

Text Mining and Determinants of Sentiments towards the COVID-19 Vaccine Booster of Twitter Users in Malaysia
by: Song-Quan Ong, et al.
Published: (2022-05-01)

Demographic Characteristics and Status of Vaccinated Individuals with a History of COVID-19 Infection Pre- or Post-Vaccination: A Descriptive Study of a Nationally Representative Sample in Saudi Arabia
by: Yazed AlRuthia, et al.
Published: (2022-02-01)

Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study
by: Muhammad Nauman Zahid
Published: (2021-11-01)

EVENTOS ADVERSOS À 3ª DOSE DAS VACINAS ASTRAZENECA E PFIZER EM UMA COORTE DE TRABALHADORES DA SAÚDE
by: Maria da Penha Gomes Gouvea, et al.
Published: (2023-10-01)

Host genetics impact on SARS-CoV-2 vaccine-induced immunoglobulin levels and dynamics: The role of TP53, ABO, APOE, ACE2, HLA-A, and CRP genes
by: Donato Gemmati, et al.
Published: (2022-11-01)

Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study
by: Krzysztof Lukaszuk, et al.
Published: (2022-03-01)

ANCA-associated vasculitis following Oxford-AstraZeneca COVID-19 vaccine in Brazil: Is there a causal relationship? A case report
by: Welder Zamoner, et al.
Published: (2022-10-01)

Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers
by: Yu-Kyung Kim, et al.
Published: (2022-01-01)

Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia
by: Adam M, et al.
Published: (2021-09-01)

Signs, Symptoms, and Side-Effects Presented by Different Types of COVID-19 Vaccines: A Prospective Cohort Study
by: Zahra Zare, et al.
Published: (2022-12-01)

An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam
by: Nguyen Van Vinh Chau, et al.
Published: (2021-11-01)

Side Effects Following Administration of the First Dose of Oxford-AstraZeneca’s Covishield Vaccine in Bangladesh: A Cross-Sectional Study
by: Nishat Jahan, et al.
Published: (2021-10-01)

Repurposing of drugs and leading vaccines work against COVID-19
by: Prabha Rana, et al.
Published: (2022-02-01)

Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
by: Lama T AlMutairi, et al.
Published: (2022-06-01)

Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients
by: Jose Rafael Teran-Tinedo, et al.
Published: (2022-06-01)

Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
by: Heba M. Attash, et al.
Published: (2022-01-01)

Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines
by: Osama Abu-Hammad, et al.
Published: (2021-06-01)

Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study
by: Adisu Asefa, et al.
Published: (2023-11-01)

Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia
by: Farhat M, et al.
Published: (2022-09-01)

Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland
by: Anna Paczkowska, et al.
Published: (2022-03-01)

Comparison of Immunogenicity and Reactogenicity of Five Primary Series of COVID-19 Vaccine Regimens against Circulating SARS-CoV-2 Variants of Concern among Healthy Thai Populations
by: Tavitiya Sudjaritruk, et al.
Published: (2023-03-01)

A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
by: Marian S. Boshra, et al.
Published: (2022-02-01)

SARIMA model-based forecasting required number of COVID-19 vaccines globally and empirical analysis of peoples’ view towards the vaccines
by: Amer Malki, et al.
Published: (2022-12-01)

Self-reported side effects of the Oxford AstraZeneca COVID-19 vaccine among healthcare workers in Ethiopia, Africa: A cross-sectional study
by: Elias Ali Yesuf, et al.
Published: (2022-07-01)

Cell immunity to SARS-CoV-2 after natural infection and/or different vaccination regimens
by: Esther Culebras, et al.
Published: (2024-03-01)

Global interest in vaccines during the COVID‐19 pandemic: Evidence from Google Trends
by: Aida Khakimova, et al.
Published: (2022-04-01)

Prevalence of COVID‐19 vaccine reactogenicity among Bangladeshi physicians
by: Md. Anwarul Azim Majumder, et al.
Published: (2022-06-01)